Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 339, Issue 4, pp 441–447 | Cite as

Sodium channel-blocking properties of flecainide, a class IC antiarrhythmic drug, in guinea-pig papillary muscles An open channel blocker or an inactivated channel blocker

  • Michio Kojima
  • Takuyuki Hamamoto
  • Takashi Ban


Effects of flecainide (a class IC antiarrhythmic drug) on the maximum rate of rise (\(\dot V_{\max } \)) of action potentials (APs) were studied in guinea-pig papillary muscles, with special reference to their time, voltage, and action potential duration (APD) dependence in the presence and absence of nicorandil. Nicorandil was used to shorten APD, i.e., the time period of inactivation state of sodium channels. APs were recorded from the preparations using standard microelectrode techniques. Flecainide (5 μmol/l) reduced\(\dot V_{\max } \) without changing resting potential, AP amplitude, APD50, and APD90 examined at 1 Hz. The drug shifted the normalized\(\dot V_{\max } \)-membrane potential curve (examined at 1/60 Hz) in the hyperpolarizing direction by 3.1 ± 0.8 mV (n = 6) (voltage dependence). The drug caused a frequency-dependent reduction of\(\dot V_{\max } \) at ≥ 0.1 Hz, developed a use-dependent reduction of\(\dot V_{\max } \) at 1 Hz with an onset time constant of 11.7 ± 0.4 s (n = 6), and slowed the recovery process of\(\dot V_{\max } \), whose resultant recovery time constant was 19.9 ± 1.2 s (n = 6) (time dependence). These flecainide-induced time-dependent reductions of\(\dot V_{\max } \) were not antagonized by nicorandil (1 mmol/1) which shortened APD to about 1/4 of control (APD independence). These results suggest that flecainide is primarily an open channel blocker because its channel-blocking actions are independent of APD or the time period of inactivation.

Key words

Flecainide Class I antiarrhythmic drugs Time, voltage, and APD dependence of sodium channel block Guinea-pig papillary muscles Cardiac electrophysiology 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bean BP, Cohen CJ, Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81:613–642Google Scholar
  2. Bigger JT (1984) Symposium on flecainide acetate. Am J Cardiol 53:1B-122BGoogle Scholar
  3. Borchard U, Boisten M (1982) Effect of flecainide on action potentials and alternating current-induced arrhythmias in mammalian myocardium. J Cardiovasc Pharmacol 4:205–212Google Scholar
  4. Campbell TJ (1983) Importance of physico-chemical properties in determining the kinetics of the effects of class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle. Br J Pharmacol 80:33–40Google Scholar
  5. Campbell TJ, Vaughan Williams EM (1983) Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new anti-arrhythmic drugs, flecainide and fecainide. Cardiovasc Res 17:251–258Google Scholar
  6. Clarkson CW, Matsubara T, Hondeghem LM (1984) Slow inactivation of Vmax in guinea pig ventricular myocardium. Am J Physiol 247:H645-H654Google Scholar
  7. Cohen CJ, Fozzard HA, Sheu S-S (1982) Increase in intracellular sodium ion activity during stimulation in mammalian cardiac muscle. Circ Res 50: 651–662Google Scholar
  8. Cohen CJ, Bean BP, Tsien RW (1984) Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers. Circ Res 54:636–651Google Scholar
  9. Ellis D (1985) Effects of stimulation and diphenylhydantoin on the intracellular sodium activity in Purkinje fibres of sheep heart. J Physiol (Lond) 362:331–348Google Scholar
  10. Gintant GA, Hoffman BF, Naylor RE (1983) The influence of molecular form of local anesthetic-type antiarrhythmic agents on reduction of the maximum upstroke velocity of canine cardiac Purkinje fibers. Circ Res 52:735–746Google Scholar
  11. Grant AO, Starmer CF, Strauss HC (1984) Antiarrhythmic drug action. Blockade of the inward sodium current. Circ Res 55:427–439Google Scholar
  12. Harrison DC (1985) Antiarrhythmic drug classification: New science and practical applications. Am J Cardiol 56:185–187Google Scholar
  13. Hauswirth O, Singh BN (1979) Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol Rev 30:5–63Google Scholar
  14. Hodges M, Salerno DM, Granrud G, the Flecainide-Quinidine Research Group (1984) Flecainide versus quinidine: results of a multicenter trial. Am J Cardiol 53:66B-71BGoogle Scholar
  15. Hondeghem LM (1985) Comments on “Maximal upstroke velocity as an index of available sodium conductance: Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers” which appeared in Circ Res 54:636–651, 1984. Circ Res 57:192–193Google Scholar
  16. Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472:373–398Google Scholar
  17. Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol 24: 387–423Google Scholar
  18. Ikeda N, Singh BN, Davis LD, Hauswirth O (1985) Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. J Am Coll Cardiol 5:303–310Google Scholar
  19. Kjekshus J, Bathen J, Orning OM, Storstein L (1984) A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. Am J Cardiol 53:72B-78BGoogle Scholar
  20. Kline RP, Morad M (1978) Potassium efflux in heart muscle during activity: Extracellular accumulation and its implications. J Physiol (Lond) 280:537–558Google Scholar
  21. Kodama I, Toyama J, Takanaka C, Yamada K (1987) Block of activated and inactivated sodium channels by class-1 antiarrhythmic drugs studied by using the maximum upstroke velocity (\(\dot V_{\max } \)) of action potential in guinea-pig cardiac muscles. J Mol Cell Cardiol 19:367–377Google Scholar
  22. Kojima M, Ban T (1988) Nicorandil shortens action potential duration and antagonises the reduction of\(\dot V_{\max } \) by lidocaine but not by disopyramide in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 337:203–212Google Scholar
  23. Kojima M, Hamamoto T, Sada H, Ban T (1988) Action potential duration dependence of\(\dot V_{\max } \) reducing actions by class I antiarrhythmic drugs in guinea-pig papillary muscles. Jpn J Pharmacol 46: Suppl 47PGoogle Scholar
  24. Martin G, Morad M (1982) Activity-induced potassium accumulation and its uptake in frog ventricular muscle. J Physiol (Lond) 328:205–227Google Scholar
  25. Matsubara T, Clarkson C, Hondeghem L (1987) Lidocaine blocks open and inactivated cardiac sodium channels. NaunynSchmiedeberg's Arch Pharmacol 336:224–231Google Scholar
  26. Nestico PF, Morganroth J, Horowitz LN (1988) New antiarrhythmic drugs. Drugs 35:286–319Google Scholar
  27. Oshita S, Sada H, Kojima M, Ban T (1980) Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 314:67–82Google Scholar
  28. Sada H, Kojima M, Ban T (1979) Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Naunyn-Schmiedeberg's Arch Pharmacol 309:179–190Google Scholar
  29. Sada H, Ban T, Oshita S (1980) Effects of mexiletine on transmembrane action potentials as affected by external potassium concentration and by rate of stimulation in guinea-pig papillary muscles. Clin Exp Pharmacol Physiol 7:583–593Google Scholar
  30. Saikawa T, Carmeliet E (1982) Slow recovery of the maximal rate of rise (\(\dot V_{\max } \)) of the action potential in sheep cardiac Purkinje fibers. Pflügers Arch 394:90–93Google Scholar
  31. Sanchez-Chapula J, Tsuda Y, Josephson IR (1983) Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells. Circ Res 52:557–565Google Scholar
  32. Somberg JC, Tepper D (1986) Flecainide: A new antiarrhythmic agent. Am Heart J 112:808–813Google Scholar
  33. Starmer CF, Courtney KR (1986) Modeling ion channel blockade at guarded binding sites: application to tertiary drugs. Am J Physiol 251:H848-H856Google Scholar
  34. Starmer CF, Grant AO (1985) Phasic ion channel blockade. A kinetic model and parameter estimation procedure. Mol Pharmacol 28:348–356Google Scholar
  35. Starmer CF, Grant AO, Strauss HC (1984) Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 46:15–27Google Scholar
  36. Wit AL, Rosen MR (1983) Pathophysiologic mechanisms of cardiac arrhythmias. Am Heart J 106:798–811Google Scholar
  37. Yabek SM, Kato R, Ikeda N, Singh BN (1987) Effects of flecainide on the cellular electrophysiology of neonatal and adult cardiac fibers. Am Heart J 113:70–76Google Scholar
  38. Yatani A, Akaike N (1985) Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide. J Mot Cell Cardiol 17:467–476Google Scholar
  39. Zipes DP (1988) Proarrhythmic events. Am J Cardiol 61:70A-76AGoogle Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • Michio Kojima
    • 1
  • Takuyuki Hamamoto
    • 1
  • Takashi Ban
    • 1
  1. 1.Department of Pharmacology, School of MedicineYamaguchi UniversityUbe, YamaguchiJapan

Personalised recommendations